首页 | 本学科首页   官方微博 | 高级检索  
   检索      

人乳头瘤病毒(HPV)31型中和单克隆抗体的制备及性质鉴定
引用本文:夏百成,刘洪洋,郝亚茹,张 婷,马铭饶,许雪梅.人乳头瘤病毒(HPV)31型中和单克隆抗体的制备及性质鉴定[J].现代生物医学进展,2020(6):1001-1005.
作者姓名:夏百成  刘洪洋  郝亚茹  张 婷  马铭饶  许雪梅
作者单位:中国医学科学院基础医学研究所 北京协和医学院基础学院 北京 100005
基金项目:中国医学科学院医学与健康科技创新工程项目基金 (2016-I2M-3-026);国家国际科技合作项目 (2013DFA32430)
摘    要:目的:构建获得HPV31构象依赖的中和单抗。方法:采用昆虫细胞表达的HPV31 L1VLP(virus-like particle, VLP)免疫BALB/c小鼠,取免疫鼠脾细胞与SP2/0细胞融合,收集杂交瘤细胞培养上清,首先采用HPV31 VLP-ELISA及HPV31假病毒中和实验筛选分泌HPV31中和单抗的杂交瘤细胞株,然后纯化单克隆抗体,分别采用假病毒中和实验及ELISA实验对纯化后单克隆抗体进行鉴定,包括抗体的亚型及其结合表位的构象特征、针对HPV31的中和IC50及针对HPV16、HPV18、HPV33、HPV45、HPV52、HPV58、HPV6、HPV11的交叉中和活性。结果:筛选获得9株HPV31构象依赖中和单抗,其中3株HPV31特异性中和单抗中有2株的IC5010 ng/mL,分别是XM31-13(0.36,Ig G1)及XM31-23(7.10,Ig G1),6株交叉中和单抗中亦有2株的IC5010ng/mL,分别是XM31-19(7.14,Ig G1)、XM31-20(6.91,Ig G1)。结论:获得的9株HPV31构象依赖的中和单抗,特别是其中4株单抗IC50值10 ng/mL的4株单抗,可用于含HPV31L1VLP多价疫苗的质控疫苗的研究。

关 键 词:人乳头瘤病毒31型  L1病毒样颗粒  单克隆抗体  中和活性
收稿时间:2019/9/27 0:00:00
修稿时间:2019/10/23 0:00:00

Preparation and Characterization of Neutralizing Monoclonal Antibodies Against Human Papillomavirus Type 31
XIA Bai-cheng,LIU Hong-yang,HAO Ya-ru,ZHANG Ting,MA Ming-rao,XU Xue-mei.Preparation and Characterization of Neutralizing Monoclonal Antibodies Against Human Papillomavirus Type 31[J].Progress in Modern Biomedicine,2020(6):1001-1005.
Authors:XIA Bai-cheng  LIU Hong-yang  HAO Ya-ru  ZHANG Ting  MA Ming-rao  XU Xue-mei
Institution:Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, 100005, China
Abstract:ABSTRACT Objective: Preparation of some conformation-dependent neutralizing monoclonal antibodies (mAbs) against HPV31. Methods: Female BALB/c mice were immunized with HPV31 L1 virus-like particles (VLPs) expressed by insect cells, and spleenocytes of the zimmunized mice were fused with SP2/0 cells to prepare hybridoma cells, the culture supernatants were-collected for identification of neutralizing mAb secreting cells by HPV31 VLP-ELISA and HPV31 pseudovirus neutralization experiments. Monoclonal antibodies were purified and identified by ELISA and HPV31, HPV16, HPV18, HPV52, HPV58, HPV33, HPV45, HPV6 or HPV11 pseudovirus neutralization experiments. Results: Nine HPV31 conformation-dependent neutralizing mAbs were screened, and three of which were HPV31 specific mAbs and the other six were cross-neutralizing mAbs.The mAbs whith IC50<10 ng/mL were XM31-13 (0.36), XM31-19 (7.14), XM31-20 (6.9), XM31-23 (7.10). Conclusion: Nine conformation-dependent neutralizing mAbs were obtained, and four of them have low IC50 value, which is useful for development of HPV31-VLP containing multivalemt vaccines.
Keywords:Human papillomavirus  Virus-like particle  Monoclonal antibody  Neutralizing activity
本文献已被 CNKI 等数据库收录!
点击此处可从《现代生物医学进展》浏览原始摘要信息
点击此处可从《现代生物医学进展》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号